Market Pulse

Event summary

• Tirana Mayor Erion Veliaj, currently incarcerated, has enlisted Kasowitz LLP and Mishcon de Reya LLP to challenge the legal appointment of Ols Dado, the lead prosecutor in his criminal case.
• Veliaj alleges Dado lacks the required qualifications (Magistracy School completion or lawful exemption) for his prosecutorial role, rendering his actions invalid.
• A May 8, 2026, hearing before the Administrative Court in Tirana will address the validity of Dado’s appointment.
• Veliaj is requesting international observers and live-streaming of the hearing to ensure transparency and due process.
• Kasowitz partner Daniel Fetterman emphasized the broader rule-of-law implications of the case.

The big picture

What we're watching

Procedural Hurdles

The Administrative Court's decision on procedural standing could preemptively dismiss Veliaj’s challenge without addressing the merits, potentially undermining the broader legal argument and raising questions about judicial impartiality.

International Response

The extent of international observer participation and any subsequent diplomatic pressure will signal the perceived importance of the case and Albania’s commitment to due process.

Prosecutorial Oversight

Regardless of the outcome, this case will likely prompt increased scrutiny of prosecutorial appointment processes and vetting procedures within Albania’s judicial system.

Event summary

• Virtus Investment Partners reported a significant decline in revenue for Q1 2026, falling 8% to $199.5 million compared to $217.9 million in Q1 2025.
• Net income attributable to Virtus Investment Partners plummeted 75% to $7.1 million, or $1.05 per diluted share, from $28.6 million, or $4.05 per diluted share, in the prior year.
• Assets under management decreased by 11% to $149.0 billion as of March 31, 2026, impacted by market performance and net outflows.
• The company completed its majority investment in Keystone National Group on March 1, 2026, for $200 million, contributing one month of results to Q1 2026.

The big picture

What we're watching

Flow Dynamics

Whether Virtus can reverse the trend of net outflows, particularly in retail separate accounts, will be crucial for stabilizing AUM and future revenue.

Keystone Integration

The pace at which Virtus can integrate Keystone’s private credit strategies and realize synergies will determine the long-term success of the acquisition.

Fee Pressure

How Virtus manages fee pressure amid increased competition and the shift towards lower-cost investment products will impact its operating margins.

Event summary

• The Doctors Company, the largest physician-owned medical malpractice insurer, released a monthly report analyzing general surgery malpractice claims.
• The report, 'General Surgery Claims: May Malpractice Risk Review,' focuses on contributing factors to patient harm, negligence allegations, and a case study of delayed postoperative complication recognition.
• The analysis highlights risks associated with colorectal surgery, including anatomical identification errors, recovery milestone monitoring failures, and inadequate documentation.
• Julie Ritzman, Senior VP of Patient Safety and Risk Management, emphasized the use of claims data to identify patterns and improve care processes.

The big picture

What we're watching

Clinical Adoption

The effectiveness of this report will depend on how readily surgeons and healthcare leaders adopt the insights and modify practices to address the identified risks, particularly regarding documentation and post-operative monitoring.

Data Breadth

The value of The Doctors Company’s insights is tied to the breadth and depth of their claims data; future reports should demonstrate expanded specialty coverage and more granular analysis to reveal broader systemic issues.

Regulatory Scrutiny

Increased focus on patient safety and post-operative care could lead to stricter regulatory oversight and potential liability for institutions failing to address the issues highlighted in this report.

Event summary

• United Airlines has launched a dedicated inflight entertainment channel featuring content from Peacock, NBCUniversal’s streaming service.
• The new channel will be available on over 160,000 seatback screens and via the United mobile app, starting May 1, 2026.
• United’s total inflight entertainment library now exceeds 1,600 hours across 800 aircraft, including content from Apple TV, HBO Max, A24, and Spotify.
• United operates a fleet of 800 aircraft with Bluetooth-enabled seatback screens, and is rolling out new planes with 27-inch 4K OLED screens.

The big picture

What we're watching

Content Costs

The long-term cost of licensing and maintaining a robust content library from Peacock and other providers will be a key factor in United's profitability, especially as it expands the offering.

Customer Adoption

Whether the addition of Peacock content will significantly increase passenger engagement with United’s inflight entertainment system remains to be seen, and will impact the ROI of this investment.

Competitive Response

Other airlines will likely follow suit with similar content partnerships, potentially leading to a commoditization of inflight entertainment and increased pressure on margins.

Event summary

• Fulgent Genetics reported Q1 2026 revenue of $71.1 million, a decrease from $73.463 million in Q1 2025.
• The company posted a GAAP loss of $24.8 million, or $(0.80) per share, and a non-GAAP loss of $11.0 million, or $(0.36) per share.
• Fulgent executed a stock repurchase program, accounting for $48.7 million in cash used and a reduction of 3.1 million shares.
• The company is updating its Non-GAAP EPS and cash guidance for the year, maintaining its revenue guidance but anticipating margin normalization in the second half.

The big picture

What we're watching

Margin Pressure

The anticipated margin normalization in the second half of 2026 will need to be closely monitored, as it suggests ongoing pricing or cost challenges within the laboratory services segment.

Pipeline Progress

The presentation of Phase 2 data for FID-007 at ASCO will be a critical inflection point, and the results will significantly influence investor sentiment regarding the therapeutic development pipeline's viability.

IRS Delays

The delayed receipt of approximately $106 million in tax refunds, due to government shutdowns, highlights a dependency on external factors and could impact the company’s cash position and future investment plans.

Event summary

• The Timken Company has agreed to sell its belts business to Gates Industrial Corporation.
• Financial terms of the deal were not disclosed.
• The transaction is expected to close in the third quarter of 2026.
• Timken cites its '80/20 approach' as the rationale for the divestiture, aiming to improve margins and focus on core competencies.
• The belts business manufactures belts for industrial, commercial, and consumer applications.

The big picture

What we're watching

Margin Impact

The disclosed expectation of improved adjusted EBITDA margins within the Industrial Motion segment warrants close monitoring; the Investor Day presentation on May 20th will be crucial for quantifying this impact and understanding the underlying drivers.

Capital Allocation

How Timken deploys the proceeds from the sale will be a key indicator of its strategic priorities; investors should scrutinize whether funds are directed towards acquisitions, debt reduction, or share buybacks.

Gates Integration

The success of Gates' integration of the belts business will determine the realized value of the acquisition; potential challenges related to operational synergies and cultural differences should be considered.

Event summary

• B2BROKER Group has upgraded its B2TRADER multi-asset trading platform with a native AI Assistant.
• The new AI Assistant provides traders with real-time forecasts, sentiment analysis, and actionable market insights directly within the platform.
• B2BROKER is introducing a more flexible pricing model for B2TRADER, tailored to broker size and operational complexity.
• B2BROKER Group was founded in 2014 and operates in 11 countries across Europe, the Middle East, and Asia.
• B2TRADER can process up to 3,000 requests per second.

The big picture

What we're watching

Adoption Rate

The success of this strategy hinges on broker adoption of the AI Assistant; slow uptake could limit B2BROKER’s return on investment and impact B2TRADER’s long-term viability.

Competitive Response

Other trading platform providers will likely accelerate their own AI integrations, potentially leading to a commoditization of AI-powered trading tools and eroding B2BROKER’s first-mover advantage.

Client Retention

B2BROKER’s ability to retain existing clients and attract new ones will depend on demonstrating tangible value from the AI Assistant beyond mere feature parity with competitors.

Event summary

• ISS is increasing its ownership stake in ISS Türkiye from 50.1% to 90%.
• Actera, previously holding 39.9% of ISS Türkiye, is exiting its investment.
• Management of ISS Türkiye retains a 10% ownership stake.
• The transaction follows a period of dialogue between ISS and Actera regarding Actera's exit strategy, initiated in 2021.

The big picture

What we're watching

Integration Risk

The full integration of Actera's operations and personnel into ISS Türkiye could present challenges, potentially impacting operational efficiency and client satisfaction.

Market Dynamics

ISS’s increased investment signals confidence in the Turkish market, but geopolitical and economic volatility in the region could still affect ISS Türkiye’s performance.

Growth Strategy

The acquisition will likely accelerate ISS’s expansion into strategic segments within Türkiye, and the success of these initiatives will be crucial for justifying the increased investment.

Event summary

• Bimergen Energy will present its $2 billion growth strategy at the Market Movers Investor Summit on May 5, 2026.
• The strategy focuses on a 2.0 GW development pipeline across key U.S. power markets (ERCOT, PJM, WECC, CAISO, MISO).
• Bimergen’s Co-CEO & CFO, Bob Brilon, will lead the presentation and Q&A session.
• The company plans to discuss a project-specific entity financial structure designed to avoid public company dilution and debt recourse.
• Bimergen is prioritizing long-term offtake agreements to de-risk cashflows and projects in Texas are expected to become operational soon.

The big picture

What we're watching

Financial Structure

The success of Bimergen’s project-specific entity financial structure will be crucial to avoiding dilution and managing debt, and its effectiveness warrants close monitoring.

Execution Risk

The rapid deployment of 2.0 GW of battery storage capacity across multiple U.S. markets presents significant execution risk, and delays or cost overruns could impact profitability.

Regulatory Headwinds

Changes in state-level regulations or grid interconnection policies could significantly impact the viability of Bimergen’s projects and revenue streams.

Event summary

• AMG's assets under management (AUM) reached a record $882 billion as of March 31, 2026.
• The company reported record positive net client cash flows of over $22 billion in Q1 2026.
• AMG's Economic Earnings Per Share (EPS) increased 58% year-over-year, reaching $8.23.
• AMG repurchased approximately $186 million in common stock during the quarter.
• Recent investments include BBH Credit Partners, HighBrook Investors, and an additional investment in Garda Capital Partners.

The big picture

What we're watching

Growth Sustainability

Whether AMG can sustain the impressive 7% organic growth rate demonstrated over the last 12 months, particularly given potential market headwinds and increased competition in alternative strategies.

Integration Risk

The success of AMG’s recent acquisitions (BBH Credit Partners, HighBrook Investors, Garda Capital Partners) will depend on effective integration and realization of anticipated synergies.

Capital Deployment

AMG's ability to continue deploying capital effectively will be crucial; the market may present opportunities or challenges that impact the returns on future investments.

Event summary

• Federal Realty Investment Trust reported Q1 2026 net income of $157.1 million, up from $61.8 million in Q1 2025.
• The company's Nareit FFO per diluted share increased 10.6% year-over-year, reaching $1.88.
• Federal Realty signed a record 101 leases for 649,078 square feet of retail space, with rent growth of 13% on a cash basis.
• The company acquired Congressional North Shopping Center for $72.3 million and an adjacent parcel at Kingstowne Towne Center for $19.7 million.

The big picture

What we're watching

Occupancy Trends

The 30-basis-point sequential occupancy decline, despite year-over-year gains, warrants scrutiny to determine if this reflects broader market headwinds or property-specific issues, potentially impacting future rent growth.

Acquisition Strategy

Federal Realty's recent acquisitions suggest a strategy of consolidating its presence in key markets; the success of these acquisitions will depend on their ability to generate returns exceeding the cost of capital.

Guidance Sustainability

The raised 2026 guidance hinges on maintaining the current pace of leasing and property performance; any slowdown in these areas could lead to a downward revision.

Event summary

• Cinemark Holdings, Inc. reported earnings for the three months ended March 31, 2026.
• The company operates approximately 500 theaters and over 5,500 screens across the U.S. and South/Central America.
• Cinemark's U.S. operations include 301 theaters and 4,219 screens, while its international operations encompass 194 theaters and 1,401 screens.
• An executive commentary accompanying the earnings release is available on Cinemark’s Investor Relations website.
• A public audio webcast and replay will be available on May 1, 2026, at 8:30 a.m. Eastern Time.

The big picture

What we're watching

Consumer Spending

Whether sustained consumer interest in theatrical releases will continue to drive attendance, particularly given broader economic uncertainties.

Premium Offerings

How Cinemark’s investments in premium offerings like XD, recliners, and D-BOX impact overall profitability and customer loyalty.

International Growth

The pace at which Cinemark can expand and maintain profitability within its South and Central American markets, given varying economic conditions.

Event summary

• Cboe Global Markets reported record Q1 2026 diluted EPS of $3.66, up 54% year-over-year.
• The company increased its 2026 organic total net revenue growth target to 'low double-digit to mid-teens' and Data Vantage growth to 'low double-digit'.
• Cboe is reducing its 2026 adjusted operating expense guidance by $15 million to $838 - $853 million.
• As part of a strategic realignment, Cboe plans to reduce its workforce by approximately 20%.

The big picture

What we're watching

Execution Risk

The success of Cboe's strategic realignment hinges on effectively integrating the changes and realizing the anticipated cost savings, which could be disrupted by employee attrition or operational inefficiencies.

Market Dynamics

Increased competition in options trading, as evidenced by the slight market share decline, will require Cboe to innovate and maintain its competitive edge.

Growth Sustainability

The ability of Cboe Data Vantage to sustain its high growth rate will depend on its ability to expand its data offerings and attract new customers in a rapidly evolving market.

Event summary

• Keenova Therapeutics will present data at Digestive Disease Week (DDW) 2026 on the use of TERLIVAZ (terlipressin) in treating hepatorenal syndrome-acute kidney injury (HRS-AKI).
• The presentation analyzes real-world treatment patterns and outcomes from seven U.S. hospitals.
• HRS-AKI incidence is rising, with projected inpatient diagnoses increasing from 42,930 in 2018 to 63,381 in 2023.
• TERLIVAZ is the only FDA-approved therapy for improving kidney function in adults with HRS-AKI, but is ineffective for patients with creatinine >5 mg/dL.

The big picture

What we're watching

Adoption Rate

The presentation’s findings could influence adoption rates of TERLIVAZ, particularly if the data highlights limitations or unexpected side effects beyond the known respiratory failure risk.

Competitive Landscape

While TERLIVAZ is currently the only approved therapy, the presentation’s data may spur research and development of alternative treatments for HRS-AKI, potentially eroding Keenova’s market exclusivity.

Regulatory Scrutiny

Given the boxed warning regarding respiratory failure, continued scrutiny from regulatory bodies regarding TERLIVAZ’s risk-benefit profile is likely, especially if the DDW presentation reveals new safety concerns.

Event summary

• Elections Canada released Q1 2026 financial returns for registered political parties.
• Parties are required to file returns if they secured at least 2% of the national vote or 5% in districts where they endorsed a candidate in the previous general election.
• Returns detail contributions, leadership contest funding, refunds, and transfers between political entities.
• The reporting period covers January 1, 2026, to March 31, 2026.

The big picture

What we're watching

Fundraising Trends

The level of post-election fundraising activity will indicate the parties' ability to maintain momentum and prepare for future campaigns, potentially revealing shifts in donor priorities.

Leadership Finance

The amount of funds directed to leadership contestants will signal internal power dynamics and potential challenges to existing leadership structures within the parties.

Transfer Dynamics

The volume and direction of transfers between political entities will provide insights into strategic alliances and resource allocation within the Canadian political landscape.

Event summary

• Chevron reported Q1 2026 earnings of $2.2 billion ($1.11/share), a decrease from $3.5 billion ($2.00/share) in Q1 2025.
• Unfavorable timing effects, totaling $2.9 billion, significantly impacted reported earnings, partially offset by upstream production growth.
• The acquisition of Hess Corporation contributed to higher U.S. oil-equivalent production, reaching over 2 million barrels per day for the third consecutive quarter.
• Cash flow from operations decreased to $2.5 billion, primarily due to higher working capital outflows related to commodity price increases.

The big picture

What we're watching

Timing Effects

The significant impact of timing mismatches on earnings highlights the potential for volatility and underscores the need to scrutinize adjusted metrics when assessing Chevron's underlying performance.

Geopolitical Risk

Continued geopolitical instability, particularly in the Middle East, poses a risk to Chevron's operations and supply chains, potentially impacting production and profitability.

Integration Risk

The full realization of synergies from the Hess acquisition remains to be seen, and any integration challenges could hinder Chevron's ability to achieve its stated goals.

Event summary

• Flowco Holdings Inc. appointed Hardy Murchison as an independent director, effective April 29, 2026.
• The board now comprises eight directors, increasing the number of independent directors to four.
• Murchison previously founded and led Encino Energy, which was acquired by EOG Resources for $5.6 billion in 2025.
• Prior to Encino, Murchison managed $1.7 billion in oil & gas investments at First Reserve Corporation.
• Murchison also held a corporate development role at Range Resources.

The big picture

What we're watching

Strategic Alignment

Murchison’s operator experience will be tested as Flowco navigates the increasing pressure to demonstrate tangible value creation beyond its technology offerings.

Governance Dynamics

The shift to a majority-independent board suggests a potential response to prior shareholder concerns or a proactive move to enhance corporate governance practices.

M&A Activity

Given Murchison’s track record in both building and divesting energy companies, his presence on the board may signal increased openness to strategic acquisitions or a potential exit strategy for Flowco.

Event summary

• Gilead Sciences executives will present at four investor conferences in May and June 2026.
• Presentations will occur at the BofA Securities, RBC Capital Markets, Bernstein, and Goldman Sachs healthcare conferences.
• Webcasts of the presentations will be available at investors.gilead.com, with replays accessible for 30 days.
• The conferences span a three-week period, beginning May 12th and concluding June 9th.

The big picture

What we're watching

Pipeline Progress

The conferences will likely be scrutinized for updates on Gilead’s oncology pipeline, given the ongoing need to diversify revenue streams beyond its established antiviral franchises.

Competitive Landscape

Management commentary regarding competition in the viral hepatitis and HIV markets will be closely watched, particularly as generic erosion continues to impact revenue.

Financial Outlook

The presentations will reveal the extent to which Gilead can sustain its current valuation, given the anticipated impact of patent expirations and the need for continued innovation.

Event summary

• Ares Management Corporation reported GAAP net income of $142.6 million for Q1 2026, with diluted EPS of $0.46.
• The company achieved record first-quarter fundraising of $30 billion, a 45% increase year-over-year.
• AUM and fee-paying AUM grew by 18% and 19% respectively, contributing to a 25% increase in management fees.
• Ares declared a quarterly dividend of $1.35 per share of Class A common stock and $0.84375 per share of its preferred stock.

The big picture

What we're watching

Fundraising Sustainability

The ability to maintain this elevated fundraising pace in subsequent quarters will be crucial, given the current macroeconomic uncertainties and potential for increased competition.

Portfolio Performance

While Ares cites strong fundamental performance across portfolios, the impact of ongoing market volatility on investment returns warrants close monitoring.

Capital Deployment

With $160 billion of available capital, Ares' strategic allocation and execution of investment opportunities will be key to realizing the potential for further growth and returns.

Event summary

• The Canadian Medical Association (CMA) issued a statement on May 1, 2026, marking National Physicians' Day.
• The statement acknowledges significant challenges facing Canadian physicians, including an aging population, workforce shortages, misinformation, and administrative burdens.
• CMA President Dr. Margot Burnell emphasized the need for increased support for doctors and a stronger public health system.
• The CMA intends to continue advocating for improvements within the Canadian healthcare system.

The big picture

What we're watching

Policy Response

The CMA's advocacy efforts will likely face resistance from provincial governments with varying healthcare priorities, potentially limiting the scope of systemic change.

Workforce Trends

The severity of physician shortages will dictate the urgency with which the government and CMA address recruitment and retention strategies, impacting patient access to care.

Misinformation Impact

The CMA's ability to combat the spread of false health information will influence public trust in medical professionals and the healthcare system's overall efficacy.